OUR FOCUS
Harnessing Transformative Trends
From advanced imaging systems to wearable devices and telemedicine platforms, Medical Technology’s boundaries are blurring with other subsectors to play a central role in improving patient outcomes and healthcare delivery.
Our Medical Technology team supports both emerging and established companies, serving as a valued partner through M&A, capital raising, and strategic transactions.
Recent transactions
$50 Million
Sole Agent
At-the-Market Facility
March 2025
$350 Million
Joint Bookrunner
Rule 144A Convertible Senior Notes Offering
March 2025
$204 Million
Joint Bookrunner
Initial Public Offering
January 2025
UNDISCLOSED
Exclusive Financial Advisor
Sale to Bausch + Lomb
December 2024
Featured Insights
Articles
April 2025
The US Gets Entresto® for a Steal
Podcasts
April 2025
Head of U.S. Public Affairs and Patient Advocacy, Oncology with Sanofi, Elizabeth Franklin, PhD, MSW
Featured Research
April 2025
